Scott Geisler, MD
Neurology · Cedar Rapids, IANPI 1336147933
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 89.6% of it on its own, with 47 other manufacturers making up the rest. Among neurology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $371.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$78K
- Philips North America LLC$6K
- Itamar Medical Inc$341
- ZOLL Respicardia, Inc.$242
- AbbVie$218
- Resmed Corp$153
- plus $2K from 42 others
What the payments were for
- Consulting fees$45,90953%
- Speaking & faculty fees$20,00023%
- Travel & lodging$8,38710%
- Food & beverage$6,3417%
- Education$630%
- Other$5,8397%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$75,489
- Dreamstat Cpap$4,958
- (8269) DreamStation Cpap$880
- Inspire Upper Airway Stimulation System$620
- remede System$242
- WatchPATONE$204
- NightBalance Und$115
- Mask$115
How this compares
$86,538 in reported general payments places this provider in the 95th percentile of 132 neurology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 18 | $236,678 |
| Adderall XrDextroamphetamine/Amphetamine | 22 | $8,872 |
| Ropinirole Hcl | 162 | $2,644 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 69 | $866 |
| Gabapentin | 83 | $584 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $306 |
| Zolpidem Tartrate | 108 | $183 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cedar Rapids
- Winthrop RiskCedar Rapids$136K
- Robert StruthersCedar Rapids$2K
- Shereen ChangCedar Rapids$2K
- Thomas RogersCedar Rapids$2K
- Laurence KrainCedar Rapids$2K
- Stephanie JacksonCedar Rapids$852
- Bruce HughesDes Moines$1.8M
- Michael JacobyDes Moines$243K
- Lynn RankinDes Moines$181K
- Wendy ZadehDes Moines$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.